AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

14,056.00p
   
  • Change Today:
    106.00p
  • 52 Week High: 15,316.00p
  • 52 Week Low: 10,120.00p
  • Currency: UK Pounds
  • Shares Issued: 1,551.00m
  • Volume: 540,550
  • Market Cap: £218,008m
  • RiskGrade: 123
  • Beta: 0.00

Latest Deals

Traded Action Notifier PriceAmountValue
14-May-26 Transfer From Pascal Soriot 0.000p 18,359 £0.00

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
14-May-26 Transfer From Pascal Soriot 0.000p 18,359 £0.00

Director Shareholdings

Notifier Holding Value*
Pascal Soriot 881,175 £123,857,958
Aradhana Sarin 98,667 £13,868,634
Marcus Wallenberg 60,028 £8,437,536
Philip A J Broadley 19,495 £2,740,217
Michel Demare 10,000 £1,405,600
Tony Mok 3,500 £491,960
Sheri McCoy 1,736 £244,012
Karen Knudsen 1,405 £197,487
Diana Layfield 1,400 £196,784
Euan Ashley 1,150 £161,644
Nazneen Rahman 720 £101,203
Anna Manz 487 £68,453

Major Shareholders

Notifier** Holding Value*
BlackRock, Inc 100,885,181 £14,180,421,041
Oddo Meriten Asset Management SA 100,885,181 £14,180,421,041
The Capital Group Companies, Inc. 77,125,348 £10,840,738,915
Wellington Management Company LLP 65,118,411 £9,153,043,850
Investor AB 51,587,810 £7,251,182,574

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 14,056.00p
Change Today 106.00p
% Change 0.76 %
52 Week High 15,316.00p
52 Week Low 10,120.00p
Volume 540,550
Shares Issued 1,551.00m
Market Cap £218,008m
Beta 0.00
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 13
Neutral 3
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 19-Feb-26 07-Aug-25
Paid 23-Mar-26 08-Sep-25
Amount 217.00¢ 103.00¢

Trades for 21-May-2026

Time Volume / Share Price
16:19 1 @ 14,024.00p
16:29 74 @ 14,056.00p
16:29 21 @ 14,056.00p
16:29 28 @ 14,056.00p
16:29 71 @ 14,056.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page